Screening for COVID-19 in Symptomatic Cancer Patients in a Cancer Hospital
Yu Fujiwara(Mount Sinai Beth Israel), Tomohiro Tsuchida(The Cancer Institute Hospital), Yasuyoshi Sato(The Cancer Institute Hospital), Shunji Takahashi(Japanese Foundation For Cancer Research), Taisuke Enokida(Japanese Foundation For Cancer Research), Yasuko Uchida(The Cancer Institute Hospital), Naoki Fukuda(The Cancer Institute Hospital), Yoshitaka Tokai(The Cancer Institute Hospital), Daisuke Ohkushi(Japanese Foundation For Cancer Research), Shinji Ohno(Unknown), Satomi Haruki(The Cancer Institute Hospital), Motoko Kubota(The Cancer Institute Hospital), Yoko Egi(The Cancer Institute Hospital), Katsunori Oikado(The Cancer Institute Hospital), Xiaofei Wang(Duke University), Yoshinori Ito(National Cancer Center Hospital East), Yuki Nakajima(The Cancer Institute Hospital), Yoshinao Sato(The Cancer Institute Hospital), Yumi Yamada, Takako Shimizu(The Cancer Institute Hospital), Koichi Takeda(IBM Research - Tokyo), Kuniko Utsugi(The Cancer Institute Hospital), Brian Hayama(Japanese Foundation For Cancer Research)
Cited by 7
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k